Dihydroergocristine mesylate is a methanesulfonic acid salt of dihydroergocristine, an ergot alkaloid derivative. It has been employed as an active pharmaceutical ingredient for symptomatic management of mental decline associated with cerebrovascular insufficiency and in peripheral vascular disease.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing DIHYDROERGOCRISTINE MESYLATE?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Dihydroergotamine mesylate
pharmaceutical raw material
Dihydro-α-ergocryptine mesylate
pharmaceutical raw material
(S,E)-N-(4-((4-CHLORO-3-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE
pharmaceutical raw material
(-)-epiafzelechin
pharmaceutical raw material
Prasteronyl Abiraterone
pharmaceutical raw material
(3alpha)-3-Acetate-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
pharmaceutical raw material
Acidihydroergocristine
pharmaceutical raw material
The international HS code for DIHYDROERGOCRISTINE MESYLATE (CAS 24730-10-7) is 2939.69.
2939.69
2939 69 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
SPXACGZWWVIDGR-SPZWACKZSA-N
CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O
Sourcing DIHYDROERGOCRISTINE MESYLATE?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.